Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Medicina|January 8, 2010
[Pulmonary-renal syndrome]Jorge A Risso, Octavio Mazzocchi, Jorge De All, et al.Medicina|February 8, 2011
[Otomastoiditis as an initial clinical manifestation of Wegener's granulomatosis]Jorge De All, Gabriel Koutnouyan, Sergio Herrando, et al.Medicina|November 8, 2011
[Vertigo and vertical nystagmus associated with intrathecal morphine administration and resolution by naloxone]Jorge De All, María Fernanda Repetto, Valeria Tagliapietra, et al.Studies in Health Technology and Informatics|August 24, 2019
Recovery Medication from Free Text to a Structured FormHumberto Fernán Mandirola Brieux, Santiago Orozco, Marisa Lanfranconi, et al.Medicina|April 10, 2026
[Post-hysterectomy chyloascites: A rare complication]Sofia Montiel, Cristina Pasaca, Melina Lopepe, et al.Diagnostics (Basel, Switzerland)|November 21, 2020
Deep Neural Frameworks Improve the Accuracy of General Practitioners in the Classification of Pigmented Skin LesionsMaximiliano Lucius, Jorge De All, José Antonio De All, et al.Medicina|January 17, 2022
[Vaping-induced lung injury]Pedro Wainer, Alejandro Decoud, Daniela Migliore, et al.Medicina|May 23, 2020
[COVID-19 experience in a private institution in Buenos Aires during the first month of the pandemic: 26 cases]Pedro Wainer, Federico Saavedra, Valeria Tagliapietra, et al.Future Cardiology|November 11, 2020
Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary interventionCamila Correa-Sadouet, A Matías Rodríguez-Granillo, Camila Gallardo, et al.Journal of Clinical Medicine|May 14, 2025
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) TrialAlfredo Matias Rodriguez-Granillo, Juan Mieres, Carlos Fernandez-Pereira, et al.Pageof 1